Researchers Discover Protein In Breast Milk That Can Disable HIV

In a study published in the Proceedings of the National Academy of Sciences, Genevieve Fouda of Duke University and colleagues describe the isolation of a “single protein called tenascin-C” in human breast milk that is believed to “disabl[e] HIV by locking onto a protein on the virus’s surface, and … is as effective at doing so as antibodies generated by the immune system for that specific purpose,” The Economist reports. “Whether tenascin-C, or something derived from it, can be deployed against HIV by doctors, rather than just by nature, remains to be seen,” the magazine notes (10/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.